Level 2 · Controlled trialRandomised controlled trial

Magnesium citrate supplementation decreased blood pressure and HbA1c in normomagnesemic subjects with metabolic syndrome: a 12-week, placebo-controlled, double-blinded pilot trial

Afitska K, Clavel J, Kisters K, Vormann J, Werner T

Magnesium research · 1 August 2021

AUTHORS’ ABSTRACT

The abstract of this article is not reproduced here: its licence does not allow it. It can be read freely on the journal’s website or on Europe PMC.

Scientific information content; it does not replace the advice of a healthcare professional. The presence of a study in this library does not constitute a claim about our products.

← All studies
Magnesium citrate supplementation decreased blood pressure and HbA1c in normomagnesemic subjects with metabolic syndrome: a 12-week, placebo-controlled, double-blinded pilot trial | Ingredient Superfood